RxWare, Inc. — Form D

RxWare, Inc. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-14. The offering totals $6.7M, of which $6.1M was reported sold. Industry: Other Health Care.

Offering

Filed: 2025-08-14
Form: D
Accession: 0001790134-25-000003
Industry: Other Health Care
Exemptions: 06b
Total offering: $6.7M
Amount sold: $6.1M
Remaining: $600K
Investors: 12
Date of first sale: 2025-08-01
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-554698

Issuer

Name: RxWare, Inc.
CIK: 0001790134
Entity type: Corporation
Jurisdiction: DELAWARE
Address: 1313 NORTH MARKET STREET, WILMINGTON, DE, 19801
Phone: 218-392-4373

Officers, directors & promoters (15)

Name	Role	Location
Shlomi Aflalo	Director	Wilmington, DE
Farhan Ashraf	Director	Wilmington, DE
Adam Fine	Director	Wilmington, DE
Raeanna Lewarne	Director	Wilmington, DE
David Matias	Director	Wilmington, DE
Harry Totonis	Director	Baltimore, MD
Shlomi Aflalo	Executive Officer	Wilmington, DE
Raeanna Lewarne	Executive Officer	Wilmington, DE
Adam E Fine	Director	New York, NY
Gregg Dearhammer	Director	Wilmington, DE
Aaron Ganz	Executive Officer	Wilmington, DE
Gregg E Dearhammer	Director	Manchester, MI
Ori E Karev	Director	Avon, CT
Yishai Knobel	Director	Bethesda, MD
Yishai Knobel	Executive Officer	Bethesda, MD

Other filings by this issuer (3)

Filed	Form	Offering	Sold
2024-12-02	D	$1.2M	$225K
2024-05-07	D	$1.0M	$700K
2019-10-04	D	$6.0M	$3.6M

More